Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-027123

Director sold 4,500 shares at $43.41 ($195,345)

  • Director acquired 4,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-14 Exercise or conversion : show line 1 in the form +4,500 $7.80 $35,100 6,004 D
2021-04-14 Sale : show line 2 in the form −4,500 $43.41 $195,345 1,504 D
Open-market sales · 4,500 sh · avg $43.41 · $195,345

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −4,500 78,500 D
Loading xslF345X03/doc4.xml…